Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients-Reference-Cited by-同舟云学术

Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients

Published:2015-06 Issue: Volume:118 Page:118-122
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Jiao Yan-mei,Weng Wen-jia,Gao Quan-sheng,Zhu Wei-jun,Cai Wei-ping,Li Ling-hua,Li Hong-jun,Gao Yan-qing,Wu Hao

Funder

Natural Science Foundation

Beijing Natural Science Foundation

Beijing science and technology plan

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference37 articles.

1. T cell receptor excision circles (TRECs), CD4+, CD8+ and their CD45RO+ and CD45RA+ subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy

2. Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial;Asmuth;J. Infect. Dis.,2010

3. Pegylated interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration;Azzoni;J. Infect. Dis.,2013

4. Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA;Beloukas;J. Clin. Microbiol.,2009

5. Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial;Boue;AIDS,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-reservoir size is not affected either by HCV coinfection or by direct acting antivirals (DAAs) therapy;Scientific Reports;2022-03-24

2. Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial;Frontiers in Immunology;2021-11-11

3. Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial;AIDS Research and Human Retroviruses;2021-06-01

4. Investigational drugs with dual activity against HBV and HIV (Review);Experimental and Therapeutic Medicine;2020-11-11

5. Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy;The Journal of Infectious Diseases;2020-06-04